Anchor price 44.93 on closest trading day on/after 2025-11-05. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | ORBIMED ADVISORS LLC | director | Sale | 184,639 | $46.22 | $8.53M |
| 2026-05-11 | Thompson Peter A. | director | Sale | 184,639 | $46.22 | $8.53M |
| 2026-05-08 | ORBIMED ADVISORS LLC | director | Sale | 59,767 | $44.58 | $2.66M |
| 2026-05-08 | Thompson Peter A. | director | Sale | 59,767 | $44.58 | $2.66M |
| 2026-05-07 | Thompson Peter A. | director | Sale | 48,546 | $44.61 | $2.17M |
| 2026-05-07 | ORBIMED ADVISORS LLC | director | Sale | 48,546 | $44.61 | $2.17M |
| 2026-04-18 | ORBIMED ADVISORS LLC | director | Sale | 2,948 | $44.52 | $131K |
| 2026-04-18 | Thompson Peter A. | director | Sale | 2,948 | $44.52 | $131K |
| 2026-04-17 | Thompson Peter A. | director | Sale | 52,397 | $44.68 | $2.34M |
| 2026-04-17 | ORBIMED ADVISORS LLC | director | Sale | 52,397 | $44.68 | $2.34M |
| 2026-04-16 | ORBIMED ADVISORS LLC | director | Sale | 226,906 | $45.34 | $10.29M |
| 2026-04-16 | Thompson Peter A. | director | Sale | 226,906 | $45.34 | $10.29M |
| 2026-04-15 | ORBIMED ADVISORS LLC | director | Sale | 235,863 | $44.64 | $10.53M |
| 2026-04-15 | Thompson Peter A. | director | Sale | 235,863 | $44.64 | $10.53M |
| 2026-04-14 | Thompson Peter A. | director | Sale | 47,814 | $44.51 | $2.13M |
| 2026-04-14 | ORBIMED ADVISORS LLC | director | Sale | 47,814 | $44.51 | $2.13M |
| 2026-03-05 | Fitzpatrick Jennifer | officer | Option exercise | 10,250 | $6.11 | $63K |
| 2026-03-05 | Fitzpatrick Jennifer | officer | Sale | 10,250 | $33.86 | $347K |
| 2026-02-03 | ORBIMED ADVISORS LLC | director | Sale | 29,063 | $44.58 | $1.30M |
| 2026-02-03 | Thompson Peter A. | director | Sale | 29,063 | $44.58 | $1.30M |
| 2026-02-02 | Thompson Peter A. | director | Sale | 1,890 | $44.57 | $84K |
| 2026-02-02 | ORBIMED ADVISORS LLC | director | Sale | 1,890 | $44.57 | $84K |
| 2026-01-22 | TPG GP A, LLC | 10%+ owner | Sale | 250,000 | $40.00 | $10.00M |
| 2026-01-02 | McKee Charlotte | officer | Award | 155,700 | $39.21 | $6.10M |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-23 | SCHEDULE 13D/A | ARTIVA BIOTHERAPEUTICS, INC. | — | 18,415,956 | view → |
| 2026-07-22 | SCHEDULE 13D/A | Freenome, Inc. | — | 15,367,270 | view → |
| 2026-07-21 | SCHEDULE 13D/A | VOR BIOPHARMA INC. | — | 12,937,855 | view → |
| 2026-07-20 | SCHEDULE 13G | Agenus Inc. | — | — | view → |
| 2026-07-07 | SCHEDULE 13D/A | Climb Bio, Inc. CLYM | 33.00% | 23,249,186 | view → |
| 2026-07-02 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | 4.10% | 1,985,541 | view → |
| 2026-06-26 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | 6.00% | 2,915,742 | view → |
| 2026-06-24 | SCHEDULE 13D/A | SOLID BIOSCIENCES INC. SLDB | — | 12,036,126 | view → |
| 2026-06-22 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | — | 3,654,307 | view → |
| 2026-06-18 | SCHEDULE 13D | Parabilis Medicines, Inc. PBLS | 23.80% | 28,933,371 | view → |
| 2026-06-15 | SCHEDULE 13D/A | ARTIVA BIOTHERAPEUTICS, INC. ARTV | 36.60% | 17,811,623 | view → |
| 2026-06-15 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | — | 5,138,703 | view → |
| 2026-06-03 | SCHEDULE 13G | Editas Medicine, Inc. EDIT | — | — | view → |
| 2026-05-21 | SCHEDULE 13G | Sana Biotechnology, Inc. SANA | — | — | view → |
| 2026-05-14 | SCHEDULE 13D/A | WEREWOLF THERAPEUTICS, INC. HOWL | — | 6,116,140 | view → |
| 2026-05-13 | SCHEDULE 13D/A | ARTIVA BIOTHERAPEUTICS, INC. ARTV | — | 16,377,468 | view → |
| 2026-01-09 | SCHEDULE | Cidara Therapeutics, Inc. | — | — | view → |
| 2025-11-07 | SCHEDULE | LENZ Therapeutics, Inc. LENZ | 13.60% | 4,265,106 | view → |
| 2025-11-03 | SCHEDULE | 89bio, Inc. | — | — | view → |
| 2025-10-01 | SCHEDULE | ARS Pharmaceuticals, Inc. SPRY | 11.10% | 10,940,977 | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →